 |
Magenta Medical
Last updated: April 17, 2024
CEO David Israeli
Country: Israel | Funding: $74M (+)
Website: http://www.magentamed.com/
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).
Website: http://www.magentamed.com/
Magenta Medical has developed a temporary venous catheter-based therapy for hospital-admitted patients with Acute Decompensated Heart Failure (ADHF).